(262 days)
No
The summary describes image processing, analysis, and comparison tools, but there is no mention of AI, ML, or related concepts like deep learning or neural networks. The performance studies focus on segmentation and registration algorithms, which are common image processing techniques that do not necessarily involve AI/ML.
No.
The device is described as a software solution for viewing, manipulating, communicating, and storing medical images, and for analyzing medical imaging data, which are diagnostic functions, not therapeutic.
Yes
This device is intended for viewing, manipulation, communication, and storage of medical images, and explicitly states it supports "interpretation and evaluation of examinations." It provides tools for analysis, segmentation, and quantification (e.g., statistical analysis, time-activity curves, quantitative results of brain regions, perfusion analysis, activity analysis, cardiac function analysis), which are all activities associated with diagnosis. The output is intended to be interpreted by a trained, licensed physician, further supporting its role in the diagnostic process.
Yes
The device description explicitly states that uWS-MI is a "comprehensive software solution" and details its functions related to processing, reviewing, and analyzing medical images. There is no mention of accompanying hardware components included with the device itself.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples such as blood, urine, or tissue that have been taken from the human body to detect diseases or other conditions.
- Device Function: The uWS-MI software is designed for viewing, manipulating, communicating, and storing medical images (PET, CT, MR). It processes and analyzes these images, which are generated from the patient, not on samples taken from the patient.
- Intended Use: The intended use clearly states it's for "viewing, manipulation, communication, and storage of medical images" and supports "interpretation and evaluation of examinations." This aligns with image analysis, not in vitro testing.
- Lack of Mention of Samples: The description focuses entirely on image data and processing, with no mention of biological samples or laboratory testing.
Therefore, the uWS-MI software falls under the category of medical image processing and analysis software, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
uWS-MI is a software solution intended to be used for viewing, manipulation, and storage of medical images. It supports interpretation and evaluation of examinations within healthcare institutions. It has the following additional indications:
The Oncology application is intended to provide tools to display and analyze the follow-up PET/CT data, with which users can do image registration, lesion segmentation, and statistical analysis.
The Dynamic Analysis application is intended to display PET data and anatomical data such as CT or MR, and supports to do lesion segmentation and output associated time-activity curve.
The Brain Analysis (NeuroQTM) application is intended to analyze the brain PET scan, give quantitative results of the relative activity of 240 different brain regions, and make comparison of activity of normal brain regions in AC database or between two studies from the same patient, as well as provide analysis of amyloid uptake levels in the brain.
The Cardiac Analysis (ECTbTM) application is intended to provide cardiac short axis reconstruction, browsing function. And it also performs perfusion analysis, activity analysis and cardiac function analysis of the cardiac short axis.
Product codes (comma separated list FDA assigned to the subject device)
LLZ
Device Description
uWS-MI is a comprehensive software solution designed to process, review and analyze PET, CT or MR Images. It can transfer images in DICOM 3.0 format over a medical imaging network or import images from external storage devices such as CD/DVDs or flash drives. These images can be functional data or anatomical datasets, such as CT. It can be at one or more time-points or include one or more time-frames. Multiple display formats including MIP and volume rendering and multiple statistical analysis including mean, maximum and minimum over a user-defined region is supported. A trained, licensed physician can interpret these displayed images as well as the statistics as per standard practice.
This Traditional 510(k) is to request modification for the cleared Picture archiving and communications system (uWS-MI) which have been cleared by FDA via K172998 on April 5, 2018.
The modifications performed on the uWS-MI (K172998) in this submission are due to the change of the basic application (Image Fusion) and the advance applications (Oncology and Dynamic Analysis).
The modifications of Brain Analysis application (NeuroQTM -- cleared by FDA via K180077) is that it can make comparison between two studies from the same patient, as well as provide analysis of amyloid uptake levels in the brain.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
PET, CT, MR
Anatomical Site
Brain, Cardiac
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained, licensed physician / healthcare institutions
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Software Verification and Validation:
- Software description
- Device Hazard Analysis
- Software requirements specification (SRS)
- Software Architecture Design Chart
- Software Development Environment Description
- Software Verification and Validation
- Cybersecurity Documents
Performance Verification:
- Performance Evaluation Report for Lung Nodule and Lymph Nodule Segmentation Algorithms
- Performance Evaluation Report for Non-rigid Registration Algorithm
- Performance Evaluation Report for Percentage Threshold Segmentation Algorithm
- Performance Evaluation Report for PET-MR Auto Registration Image Fusion
Key results: The features described in this premarket submission are supported with the results of the testing mentioned above; the uWS-MI was found to have a safety and effectiveness profile that is similar to the predicate device and reference devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
K183170, K173897, K180077, K123646
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: on the left, there is a seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular pattern around a symbol. On the right, there is the text "FDA U.S. FOOD & DRUG ADMINISTRATION" in blue. The word "FDA" is in a larger font and is placed inside a blue square.
Shanghai United Imaging Healthcare Co., Ltd. Jiading District % Xin Gao Regulatory Affairs Manager NO. 2258 Chengbei Road Shanghai, Shanghai 201807 CHINA
Re: K192630
Trade/Device Name: uWS-MI Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: Class II Product Code: LLZ Dated: May 9, 2020 Received: May 13, 2020
Dear Xin Gao:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
June 11, 2020
1
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
For
Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K192630
Device Name uWS-MI
Indications for Use (Describe)
uWS-MI is a software solution intended to be used for viewing, manipulation, and storage of medical images. It supports interpretation and evaluation of examinations within healthcare institutions. It has the following additional indications:
The Oncology application is intended to provide tools to display and analyze the follow-up PET/CT data, with which users can do image registration, lesion segmentation, and statistical analysis.
The Dynamic Analysis application is intended to display PET data and anatomical data such as CT or MR, and supports to do lesion segmentation and output associated time-activity curve.
The Brain Analysis (NeuroQ™) application is intended to analyze the brain PET scan, give quantitative results of the relative activity of 240 different brain regions, and make comparison of activity of normal brain regions in AC database or between two studies from the same patient, as well as provide analysis of amyloid uptake levels in the brain.
The Cardiac Analysis (ECTb™) application is intended to provide cardiac short axis reconstruction, browsing function. And it also performs perfusion analysis, activity analysis and cardiac function analysis of the cardiac short axis.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the words "UNITED IMAGING" in bold, sans-serif font, stacked on top of each other. To the right of the text is a stylized "U" shape, which is formed by two vertical lines and a horizontal line in the middle. The logo is simple and modern, and the colors are muted.
SECTION 3
510(k) Summary
4
Image /page/4/Picture/1 description: The image contains the logo for United Imaging. The words "UNITED IMAGING" are in bold, sans-serif font, stacked on top of each other. To the right of the text is a stylized "U" symbol, which is also in bold. The logo is simple and modern, with a focus on the company name and a distinctive symbol.
510 (k) SUMMARY
1. Date of Preparation:
May 9, 2020
2. Sponsor Identification
Shanghai United Imaging Healthcare Co.,Ltd. No.2258 Chengbei Rd. Jiading District, 201807, Shanghai, China
Establishment Registration Number: 3011015597
Contact Person: Xin GAO Position: Regulatory Affairs Manager Tel: +86-021-67076888-5386 Fax: +86-021-67076889 Email: xin.gao@united-imaging.com
3. Identification of Proposed Device
Trade Name: uWS-MI Common Name: Image Post Processing Software Model(s): uWS-MI
Regulatory Information Classification Name: Picture archiving and communications system Classification: II Product Code: LLZ Regulation Number: 21 CFR 892.2050 Review Panel: Radiology
4. Identification of Predicate Device(s)
Predicate Device 510(k) Number: K172998 Device Name: uWS-MI
Reference Device#1 510(k) Number: K183170 Device Name: uWS-CT
5
Image /page/5/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the words "UNITED IMAGING" stacked on top of each other in a bold, sans-serif font. To the right of the text is a stylized "U" shape, which is formed by two vertical lines and a curved line at the bottom. The logo is simple and modern, and the use of bold text and a clean design gives it a professional look.
Reference device#2 510(k) Number: K173897 Device Name: syngo.via MI Workflows
Reference device#3 510(k) Number: K180077 Device Name: NeuroQTM3.8
Reference device#4 510(k) Number: K123646 Device Name: Emory Cardiac Toolbox™4.0
5. Device Description
uWS-MI is a comprehensive software solution designed to process, review and analyze PET, CT or MR Images. It can transfer images in DICOM 3.0 format over a medical imaging network or import images from external storage devices such as CD/DVDs or flash drives. These images can be functional data or anatomical datasets, such as CT. It can be at one or more time-points or include one or more time-frames. Multiple display formats including MIP and volume rendering and multiple statistical analysis including mean, maximum and minimum over a user-defined region is supported. A trained, licensed physician can interpret these displayed images as well as the statistics as per standard practice.
This Traditional 510(k) is to request modification for the cleared Picture archiving and communications system (uWS-MI) which have been cleared by FDA via K172998 on April 5, 2018.
The modifications performed on the uWS-MI (K172998) in this submission are due to the change of the basic application (Image Fusion) and the advance applications (Oncology and Dynamic Analysis).
The modifications of Brain Analysis application (NeuroQ™ -- cleared by FDA via K180077) is that it can make comparison between two studies from the same patient, as well as provide analysis of amyloid uptake levels in the brain.
6. Indications for use
uWS-MI is a software solution intended to be used for viewing, manipulation,
6
Image /page/6/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the words "UNITED IMAGING" in bold, sans-serif font, stacked on top of each other. To the right of the text is a stylized icon that resembles a shield with a white cross-like shape in the center. The overall design is clean and modern.
communication, and storage of medical images. It supports interpretation and evaluation of examinations within healthcare institutions. It has the following additional indications:
The Oncology application is intended to provide tools to display and analyze the followup PET/CT data, with which users can do image registration, lesion segmentation, and statistical analysis.
The Dynamic Analysis application is intended to display PET data and anatomical data such as CT or MR, and supports to do lesion segmentation and output associated timeactivity curve.
The Brain Analysis (NeuroQ™) application is intended to analyze the brain PET scan, give quantitative results of the relative activity of 240 different brain regions, and make comparison of activity of normal brain regions in AC database or between two studies from the same patient, as well as provide analysis of amyloid uptake levels in the brain.
The Cardiac Analysis (ECT6TM) application is intended to provide cardiac short axis reconstruction, browsing function. And it also performs perfusion analysis, activity analysis and cardiac function analysis of the cardiac short axis.
7. Technological Characteristic
The technology characteristics of the modified uWS-MI, reflected in this 510(k) submission, do not alter the scientific technology of the devices and are substantially equivalent to those of the predicate and reference devices.
The following tables compare the main features, principles of operation, fundamental scientific technology and intended use of uWS-MI when compared to the predicate devices.
7
Image /page/7/Picture/1 description: The image shows the logo for United Imaging. The words "UNITED IMAGING" are stacked on top of each other in a bold, sans-serif font. To the right of the text is a stylized "U" symbol, which is composed of two vertical bars connected by a horizontal bar at the top.
| Item | Proposed Device | Predicate Device | Remark |
|---|---|---|---|
| uWS-MI | uWS-MI (K172998) | ||
| Device Classification | |||
| Name | Picture Archiving and Communications | ||
| System | Picture Archiving and Communications | ||
| System | Same | ||
| Product Code | LLZ | LLZ | Same |
| Regulation Number | 21 CFR 892.2050 | 21 CFR 892.2050 | Same |
| Device Class | II | II | Same |
| Classification Panel | Radiology | Radiology | Same |
| Advanced Application | Yes | Yes | Same |
| Indications for use | uWS-MI is a software solution intended | ||
| to be used for viewing, manipulation, | |||
| communication, and storage of medical | |||
| images. It supports interpretation and | |||
| evaluation of examinations within | |||
| healthcare institutions. It has the | |||
| following additional indications: |
The Oncology application is intended to
provide tools to display and analyze the
follow-up PET/CT data, with which users
can do image registration, lesion
segmentation, and statistical analysis.
The Dynamic Analysis application is
intended to display PET data and
anatomical data such as CT or MR, and
supports to do lesion segmentation and
output associated time-activity curve. | uWS-MI is a software solution intended
to be used for viewing, manipulation,
communication, and storage of medical
images. It supports interpretation and
evaluation of examinations within
healthcare institutions. It has the
following additional indications:
The PET/CT Oncology application is
intended to provide tools to display and
analyze the follow-up PET/CT data, with
which users can do image registration,
lesion segmentation, and statistical
analysis.
The PET/CT Dynamic Analysis
application is intended to display the
dynamic PET image data and its
associated time-activity curve. | The indication for use of
the proposed device is
expanded and replenished.
The proposed device
includes more functions
under each same
application as the predicate
device. This difference
will not affect the safety
and effectiveness. |
8
Image /page/8/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the words "UNITED IMAGING" in bold, sans-serif font, stacked on top of each other. To the right of the text is a stylized "U" symbol. The symbol is dark gray and has a white vertical line running through the center, creating a negative space effect.
| | The Brain Analysis (NeuroQTM)
application is intended to analyze the
brain PET scan, give quantitative results
of the relative activity of 240 different
brain regions, and make comparison of
activity of normal brain regions in AC
database or between two studies from the
same patient, as well as provide analysis
of amyloid uptake levels in the brain.
The Cardiac Analysis (ECTbTM)
application is intended to provide cardiac
short axis reconstruction, browsing
function. And it also performs perfusion
analysis, activity analysis and cardiac
function analysis of the cardiac short
axis. | The PET/CT Brain Analysis (NeuroQTM)
application is intended to analyze the
brain PET scan, give quantitative results
of the relative activity of 240 different
brain regions, and make comparison of
activity of normal brain regions in AC
database.
The PET/CT Cardiac Analysis (ECTbTM)
application is intended to provide cardiac
short axis reconstruction, browsing
function. And it also performs perfusion
analysis, activity analysis and cardiac
function analysis of the cardiac short
axis. | | | | |
|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------|--|--|--|
| Specification | | | | | | |
| Image communication | Yes | Yes | Same | | | |
| Hardware /OS | Yes | Yes | Same | | | |
| Patient Administration | Yes | Yes | Same | | | |
| Review 2D | Yes | Yes | Same | | | |
| Review 3D | Yes | Yes | Same | | | |
| Filming | Yes | Yes | Same | | | |
| Image Fusion | Yes | Yes | Modify a function under
this Application | | | |
| Inner View | Yes | Yes | Same | | | |
9
| Visibility | Yes | Yes | Same |
|---|---|---|---|
| ROI/VOI | Yes | Yes | Same |
| MIP Display | Yes | Yes | Same |
| Compare | Yes | Yes | Same |
| Report | Yes | Yes | Same |
SE Discussion for Modified Advanced Applications 1.
| Application | Function name | Proposed device
uWS-MI | Predicate Device
uWS-MI
(K172998) | Remark |
|---------------------|--------------------------------------|---------------------------|-----------------------------------------|--------------------------------------------------------------------|
| Dynamic
Analysis | Reframe/Rebin | Yes | Yes | Same |
| | ROI Analysis | Yes | Yes | Same |
| | Pseudo color | Yes | Yes | Same |
| | Automatic cine | Yes | Yes | Same |
| | Curve Analysis | Yes | Yes | Same |
| | Table Statistics | Yes | Yes | Same |
| | Save | Yes | Yes | Same |
| | Filming | Yes | Yes | Same |
| | Manual registration | Yes | Yes | Same |
| | Auto registration | Yes | Yes | Same |
| | Dot registration | Yes | Yes | Same |
| | Fix threshold Segmentation | Yes | Yes | Same |
| | Adaptive threshold
Segmentation | Yes | Yes | Same |
| | Percentage threshold
segmentation | Yes | NO | New Function which will not
impact safety and
effectiveness. |
10
Image /page/10/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the words "UNITED IMAGING" in bold, sans-serif font, stacked on top of each other. To the right of the text is a stylized "U" symbol, which is also in a bold font. The color of the logo is a dark teal.
| Application | Function name | Proposed
device
uWS-MI | Predicate
Device
uWS-MI
(K172998) | Reference
device#1:
uWS-CT
(K183170) | Reference
device#2:
syngo.via MI
Workflows
(K173897) | Remark |
|----------------------------|---------------------------------------------|------------------------------|--------------------------------------------|-----------------------------------------------|------------------------------------------------------------------|----------------------------------------------------------------------------|
| Oncology | Compare display | Yes | Yes | / | / | Same |
| | Auto registration | Yes | Yes | / | / | Modified function
which will not impact
safety and
effectiveness. |
| | Manual registration | Yes | Yes | / | / | Same |
| | Spread | Yes | Yes | / | / | Same |
| | Statistical Analysis | Yes | Yes | / | / | Same |
| | Save | Yes | Yes | / | / | Same |
| | Fix Segmentation | Yes | Yes | / | / | Same |
| | Adaptive Segmentation | Yes | Yes | / | / | Same |
| | Percentage threshold
lesion segmentation | Yes | No | / | / | New Function which
will not impact safety
and effectiveness. |
| | Lung Nodule
Segmentation | Yes | / | Yes | / | Same |
| | Liver Tumor
Segmentation | Yes | / | Yes | / | Same |
| Lymph Node
Segmentation | Yes | / | | Yes | Same | |
11
Image /page/11/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the words "UNITED IMAGING" in bold, sans-serif font, stacked on top of each other. To the right of the words is a stylized "U" symbol, which is also in a bold, sans-serif font. The logo is in a dark gray color.
| Application | Function name | Proposed device
uWS-MI | Reference device#3:
NeuroqTM
(K180077) | Remark |
|---------------------------------|-----------------------------------------------|---------------------------|----------------------------------------------|--------|
| Brain
Analysis
(NeuroqTM) | Reformat | Yes | Yes | Same |
| | Quality Control | Yes | Yes | Same |
| | Slice Display | Yes | Yes | Same |
| | Compare | Yes | Yes | Same |
| | PET/CT Fusion | Yes | Yes | Same |
| | EQuAL analysis | Yes | Yes | Same |
| | AmyQ | Yes | Yes | Same |
| | Save results, Capture
region/display, Exit | Yes | Yes | Same |
| | 3D Display | Yes | Yes | Same |
| Application | Function name | Proposed device
uWS-MI | Reference device#4
Syntermed Emory Cardiac
ToolboxTM (K123646) | Remark |
|--------------------------------------------------------|---------------------------------------------|---------------------------|----------------------------------------------------------------------|--------|
| Cardiac
Analysis
(Emory
Cardiac
ToolboxTM) | Reconstruction | Yes | Yes | Same |
| | SSS | Yes | Yes | Same |
| | Polor Maps | Yes | Yes | Same |
| | Perfusion Analysis | Yes | Yes | Same |
| | Viability Analysis | Yes | Yes | Same |
| | Functional Analysis | Yes | Yes | Same |
| | Save results, Capture region/display , Exit | Yes | Yes | Same |
12
Image /page/12/Picture/1 description: The image contains the logo for United Imaging. The words "UNITED" and "IMAGING" are stacked on top of each other in bold, sans-serif font. To the right of the text is a stylized "U" symbol, which is also in bold and appears to be a solid color. The logo is simple and modern in design.
| How
1001 | I AD | C
I W | Same |
|-------------|------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------|
| ﻟ | ह
r UD | ન તાલુ
ﺗﺄﺳﻴﺴﺎﺕ ﺳﻨﺔ 1999 ﻓﻲ ﺇﺳﺒﺎﻧﻴﺎ، ﻭﻳﺘﺤﺪ ﺍﻟﻤﺪﻳﻨﺔ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟ | Same |
13
Image /page/13/Picture/1 description: The image contains the logo for United Imaging. The words "UNITED IMAGING" are stacked on top of each other and are in a bold, sans-serif font. To the right of the words is a stylized "U" shape that is dark gray. The logo is simple and modern.
8. Performance Data
The following performance data were provided in support of the substantial equivalence determination.
Biocompatibility
Not Applicable to the proposed device, because the device is stand-alone software.
Electrical Safety and Electromagnetic Compatibility (EMC)
Not Applicable to the proposed device, because the device is stand-alone software.
Software Verification and Validation
Software verification and validation testing was provided to demonstrate safety and efficacy of the proposed device. This includes a hazard analysis, and the potential hazards have been classified as a moderate level of concern (LOC). Those documentations include:
- Software description
- Device Hazard Analysis
- · Software requirements specification (SRS)
- · Software Architecture Design Chart
- · Software Development Environment Description
- · Software Verification and Validation
- · Cybersecurity Documents
Animal Study
No animal study was required.
Clinical Studies
No clinical study was required.
Performance Verification
- . Performance Evaluation Report for Lung Nodule and Lymph Nodule Segmentation Algorithms
- Performance Evaluation Report for Non-rigid Registration Algorithm
- . Performance Evaluation Report for Percentage Threshold Segmentation Algorithm
- . Performance Evaluation Report for PET-MR Auto Registration Image Fusion
Other Standards and Guidance
14
Image /page/14/Picture/1 description: The image contains the logo for United Imaging. The words "UNITED IMAGING" are stacked on top of each other and are in a bold, sans-serif font. To the right of the text is a stylized "U" shape, which is likely a graphical representation of the company's initial. The logo is simple, modern, and professional in appearance.
- NEMA PS 3.1 3.20 Digital Imaging and Communications in Medicine . (DICOM) Set (2016).
- . ISO 14971 Medical devices - Application of risk management to medical devices (Edition 2.0, corrected version, 2007).
- . IEC 62304 Medical device software - Software life cycle processes (Edition 1.1, 2015).
Summary
The features described in this premarket submission are supported with the results of the testing mentioned above; the uWS-MI was found to have a safety and effectiveness profile that is similar to the predicate device and reference devices.
9. Substantial Equivalent Conclusion
The proposed device is equivalent to the predicate device with regard to safety and efficacy. This conclusion is based upon a comparison of intended use, technological characteristics, performance specification, device hazards as well as verification and validation results.
In summary, the proposed device is determined to be Substantial Equivalent to the predicate device and reference devices.